IOVA icon

Iovance Biotherapeutics

84 hedge funds and large institutions have $349M invested in Iovance Biotherapeutics in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

3% less capital invested

Capital invested by funds: $361M → $349M (-$11.8M)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.43M
Puts
$186K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.32M
27
$1.24M
28
$1.08M
29
$1.02M
30
$688K
31
$677K
32
$655K
33
$528K
34
$524K
35
$468K
36
$456K
37
$453K
38
$380K
39
$375K
40
$373K
41
$364K
42
$318K
43
$316K
44
$308K
45
$291K
46
$287K
47
$270K
48
$250K
49
$241K
50
$236K